Your Quick Guide on MK4541

A new selective androgen receptor modulator (SARM) called MK4541 is starting to make a name for itself in the pharmaceutical world for its ability to help improve the quality of life among men with prostate cancer.

 

Let’s give this compound a closer look…

 

The Rundown on MK4541

 

At its simplest, MK4541 is designed to get rid of androgen-independent prostate cancer cells by inducing their death in men suffering from the disease.

 

Now while there are already a number of treatments and preventive options for the enlargement of the prostate and prostate cancer available these days, they tend to mess up the body’s ideal androgen levels in the long run.

 

This disruption leads to a number of adverse behavioral and musculoskeletal side effects like sexual dysfunction, osteoporosis and bone fractures as well as mood swings sooner or later.

 

What makes MK4541 different from these treatments is it has the ability to induce apoptosis or programmed cell death in prostate cancer cells without causing the body to get into an androgen deficient condition.This means that this SARM could help get rid of prostate cancer without causing the adverse side effects promoted by traditional treatments available nowadays.

 

This compound is still currently being assessed in a battery of clinical trials to see its full efficacy.

 

Surprising Added Benefits

 

What’s really interesting about MK4541 is it set off some rather surprising additional benefits when administered to male rats.

 

Besides being seen to stave off androgen-dependent prostate growth, this SARM also helped maintain ideal bone density and lean body mass in the process. Experts even imagine that MK4541 may hold more anabolic benefits and should be studied further.

 

We will update this post as soon as we can when there are new developments on MK4541. In the meantime, you can also check out other SARMS right here.

 

The post Your Quick Guide on MK4541 appeared first on Info on SARMs at SarmStore1.com.

Your Quick Guide on MK4541

A new selective androgen receptor modulator (SARM) called MK4541 is starting to make a name for itself in the pharmaceutical world for its ability to help improve the quality of life among men with prostate cancer.

 

Let’s give this compound a closer look…

 

The Rundown on MK4541

 

At its simplest, MK4541 is designed to get rid of androgen-independent prostate cancer cells by inducing their death in men suffering from the disease.

 

Now while there are already a number of treatments and preventive options for the enlargement of the prostate and prostate cancer available these days, they tend to mess up the body’s ideal androgen levels in the long run.

 

This disruption leads to a number of adverse behavioral and musculoskeletal side effects like sexual dysfunction, osteoporosis and bone fractures as well as mood swings sooner or later.

 

What makes MK4541 different from these treatments is it has the ability to induce apoptosis or programmed cell death in prostate cancer cells without causing the body to get into an androgen deficient condition.This means that this SARM could help get rid of prostate cancer without causing the adverse side effects promoted by traditional treatments available nowadays.

 

This compound is still currently being assessed in a battery of clinical trials to see its full efficacy.

 

Surprising Added Benefits

 

What’s really interesting about MK4541 is it set off some rather surprising additional benefits when administered to male rats.

 

Besides being seen to stave off androgen-dependent prostate growth, this SARM also helped maintain ideal bone density and lean body mass in the process. Experts even imagine that MK4541 may hold more anabolic benefits and should be studied further.

 

We will update this post as soon as we can when there are new developments on MK4541. In the meantime, you can also check out other SARMS right here.

 

The post Your Quick Guide on MK4541 appeared first on Info on SARMs at SarmStore1.com.

Ostarine

 
 

Ostarine also known as MK-2866 was developed in 2009 by the Gtx Company as an experimental drug for fighting muscle wasting diseases. It accidentally became a side effect drug for fighting stubborn injuries. Ostarine is in the SARMs (Selective Androgen Receptor Modulators) class of drugs. Ostarine is selective as it binds only to the bone […]

 

The post Ostarine appeared first on Karen Gallagher.

Tim Means Speaks Out on His USADA Violation

Tim Means finally voices out on the recent violation notice he received from the U.S. Anti-Doping Agency (USADA).

 

The 32-year old welterweight fighter from Albuquerque, New Mexico points out that he is really confused why he failed the drug test administered by the agency before his UFC Fight Night 83 bout with Donald Cerrone on February 21.

 

The Dirty Bird even adds that he can’t quite put his finger on the reason why he flunked the drug test and it’s very annoying for him to be pulled out from his main event match in Pittsburgh against Cerrone without fully understanding the basis for the same.

 

USADA’s Doping Allegations Against Tim Means

 

Means stresses that USADA informed him through email that he failed the drug test because the sample he submitted to them contained traces of Ostarine, a type of selective androgen receptor modulator (SARM) that sets off very similar effects to anabolic steroids when synthesized by the body.

 

Apart from picking up the pace on burning off fat, this SARM also enhances the body’s ability to build lean muscle. However, unlike steroids that can trigger adverse side effects like hair loss and prostate problems, Ostarine and its other SARM counterparts like S4 (Andarine) and LGD-4033 don’t have the ability to cause these issues.

 

At its simplest, USADA considers the use of these substances as similar to “doping.” What’s even worse is that the former King of the Cage Junior Welterweight Champion and Legacy FC contender is facing a possible a suspension of up to 4 years for the failed drug test.

 

The Possibility of a Botched Lab Test or Full Non-Disclosure of Ingredients

 

Tim Means reveals that what’s really confusing about the whole thing is he hasn’t used Ostarine or any other SARM while training for his UFC fight. He theorizes that the reason for his failing the drug test may be due to tainted lab equipment or perhaps one of the supplements he’s using contained the substance, but did not clearly indicate it in the list of ingredients.

 

The American mixed martial arts (MMA) professional says that he isn’t simply dodging the issue because he owns up to his mistakes and doesn’t have the habit of blaming others for them. Means adds that while it’s true that he made bad decisions in the past involving drugs, this issue with Ostarine is not making sense to him.

 

Owning Up and Biased Accusations

 

“I haven’t done anything wrong,” the UFC welterweight shares. “I did not intentionally ingest an anabolic agent.” As for the potential suspension, he divulges that he is currently looking into getting another job unrelated to MMA to take care of the bills and his other responsibilities.

 

Tim Means also expresses his disappointment to all the negative comments thrown at him, especially those that already accuse him of being guilty. “It’s easy to judge when you’re sitting on the outside looking in,” he stresses. “Let the findings all be heard and let both sides be told.”

 

The post Tim Means Speaks Out on His USADA Violation appeared first on Info on SARMs at SarmStore1.com.